Thomas E Bickett

8PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 10, 2024
Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.

Laurel B Darragh, Michael M Knitz, Junxiao Hu

|Dec 28, 2022
Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.

Laurel B Darragh, Michael M Knitz, Junxiao Hu

|Nov 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.

Laurel B Darragh, Michael M Knitz, Junxiao Hu

|Dec 04, 2021
Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma.

Miles Piper, Benjamin Van Court, Adam Mueller

|Sep 14, 2021
FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC.

Thomas E Bickett, Michael Knitz, Laurel B Darragh

|Apr 22, 2021
Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.

Michael W Knitz, Thomas E Bickett, Laurel B Darragh

Pageof 2

Frequent Collaborators

7 joint publications

Michael W Knitz

4 joint publications

Sana D Karam

4 joint publications

Laurel B Darragh

3 joint publications

Miles Piper